home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Two Studies on Metastatic Melanoma Cells Offer Promise for Drugs/Diagnosis

  August, 6 2000 9:18
your information resource in human molecular genetics

Malignant melanoma is an aggressive form of skin cancer, linked to sunlight. The biggest clinical threat to sufferers is often metastasis, the poorly understood process by which tumour cells spread through the body, evading detection and destruction.

This week (Nature, Vol. 406, Issue 6795, pp532-535, 536-540, August 3, 2000) two studies focus on the metastasis of melanoma cells. Richard O. Hynes of the Massachusetts Institute of Technology and co-workers identify several genes that are overexpressed in metastatic melanoma cells. In particular, one of these genes alone - RhoC - stimulates metastasis in a mouse model, raising the possibility that the RhoC protein could be used as a target for antimetastatic drugs.

In the second study, Jeffrey Trent of the National Human Genome Research Institute and colleagues compare different subgroups of human melanoma and find a distinctive pattern of gene expression in highly invasive melanoma cells, with implications for improving diagnostic procedures.

The two research groups used the new approach of 'gene expression profiling'. This technique is "revolutionizing our approach to studying cancer," says Anne Ridley of University College London in an accompanying News and Views article.

Richard Hynes
tel +1 617 253 6422, fax +1 617 253 8537,
e-mail rohynes@mit.edu

Jeffrey Trent
tel +1 301 402 2023, fax +1 301 402 2040,
e-mail jtrent@nhgri.nih.gov

Anne Ridley
tel +44 207 878 4033, fax +44 207 878 4040, e-mail anne@ludwig.ucl.ac.uk

(C)Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.